Reversal of Remimazolam by a Single Dose of Flumazenil

Clinical trial NCT05382806 · COMPLETED

Trial details

NCT number: NCT05382806
Sponsor: Konkuk University Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Flumazenil Adverse Reaction Ambulatory Surgery Postoperative Nausea Remimazolam

Start date: 2022-08-02
Primary completion: 2023-05-10
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.